Sarepta 治療公司
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionProfund Advisors Llc
Latest Disclosed Ownership74,010 shares
Latest Disclosed Value $ 1,610,458
Profund Advisors Llc reports 2.90% decrease in ownership of SRPT / Sarepta Therapeutics, Inc.

On April 24, 2026 - Profund Advisors Llc filed a 13F-HR form disclosing ownership of 74,010 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $1,610,458 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 76,224 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of -2.90% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 74,010 -2,214 -2.90 1,610 -1.83 0.0591
2026-02-06 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 76,224 37,350 96.08 1,640 118.96 0.0498
2025-11-06 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 38,874 7,085 22.29 749 37.94 0.0243
2025-08-07 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 31,789 10,161 46.98 544 -60.65 0.0196
2025-05-08 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 21,628 -389 -1.77 1,380 -48.45 0.0600
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 22,017 -6,358 -22.41 2,677 -24.44 0.0977
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 28,375 78 0.28 3,544 -20.74 0.1341
2024-08-13 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 28,297 17,132 153.44 4,471 209.34 0.1658
2024-05-08 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 11,165 -5,112 -31.41 1,445 -7.90 0.0563
2024-02-14 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 16,277 4,087 33.53 1,570 6.23 0.0674
2023-11-13 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 12,190 638 5.52 1,478 11.72 0.0817
2023-08-10 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 11,552 2,960 34.45 1,323 11.66 0.0710
2023-05-12 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 8,592 -1,200 -12.25 1,184 -6.62 0.0732
2023-02-02 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 9,792 243 2.54 1,269 20.08 0.0823
2022-11-07 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 9,549 -449 -4.49 1,056 40.99 0.0760
2022-08-01 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 9,998 -850 -7.84 749 -11.57 0.0476
2022-05-10 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 10,848 -1,127 -9.41 847 -21.43 0.0356
2022-02-08 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 11,975 -975 -7.53 1,078 -10.02 0.0352
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 12,950 -665 -4.88 1,198 13.23 0.0404
2021-08-12 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 13,615 -377 -2.69 1,058 1.44 0.0355
2021-05-14 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 13,992 -2,088 -12.99 1,043 -61.95 0.0401
2021-02-09 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 16,080 1,484 10.17 2,741 33.71 0.1198
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 14,596 -1,823 -11.10 2,050 -22.14 0.1055
2020-08-03 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 16,419 3,115 23.41 2,633 102.38 0.1465
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 13,304 -4,854 -26.73 1,301 -44.47 0.0977
2020-02-18 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 18,158 1,905 11.72 2,343 91.42 0.1020
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 16,253 -918 -5.35 1,224 -53.09 0.0619
2019-08-13 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 17,171 -1,295 -7.01 2,609 18.54 0.1237
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 18,466 248 1.36 2,201 10.71 0.1058
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 18,218 -3,125 -14.64 1,988 -42.33 0.1230
2018-11-13 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 21,343 21,343 3,447 0.1308
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.